Spatially optimized 125I brachytherapy: a novel immunomodulatory approach based on spatially fractionated radiation therapy principles.

ABSTRACT: Conventional ¹²⁵I brachytherapy, emphasizing uniform dose coverage, may limit its potential to activate anti-tumor immunity. We propose integrating the principles of Spatially Fractionated Radiotherapy (SFRT) into ¹²⁵I brachytherapy. Through a heterogeneous dose design featuring "co-existing high- and low-dose regions", this approach aims to synergize immunogenic cell death (ICD) with the preservation of immune cell function, thereby transforming the tumor into an "in situ vaccine". The inherent characteristics of ¹²⁵I sources - namely, the steep dose gradient of their low-energy gamma rays and continuous low-dose-rate delivery - provide unique advantages for the precise construction of distinct regions: a high-dose zone (to induce ICD) and a low-dos

SUBMITTER: Sun Q 

PROVIDER: S-EPMC12714662 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature